Tyme Investor Relations Material
Latest events
Q3 2022
Tyme
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tyme Technologies Inc
Access all reports
Tyme Technologies Inc was a biotechnology company that developed cancer metabolism-based therapies aimed at targeting and disrupting cancer cell metabolism. The company focused on developing novel therapeutic candidates for the treatment of various types of cancer. Tyme Technologies served the oncology sector through research-driven initiatives. The company was headquartered in Bedminster, New Jersey, and its shares were listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
TYME
Country
🇺🇸 United States